183
Participants
Start Date
March 31, 2016
Primary Completion Date
February 21, 2019
Study Completion Date
February 21, 2019
ADCT-402
intravenous infusion
Columbia University Medical Center Herbert Irving Pavilion, New York
Greenville Health System, Institute for Translational Oncology Research, Clinical Research Unit, Greenville
Winship Cancer Institute of Emory University, Atlanta
Blood and Marrow Transplant Group of Georgia, Atlanta
University Hospitals of Cleveland, Cleveland
Froedtert Hospital & the Medical College of Wisconsin, Milwaukee
Washington University School of Medicine, St Louis
UC San Diego Moores Cancer Center, La Jolla
U.O Oncologia e Ematologia - Istituto Clinico Humanitas, Milan
University College London Hospitals, London
The Christie NHS Foundation Trust, Manchester
Lead Sponsor
ADC Therapeutics S.A.
INDUSTRY